lunularin has been researched along with Leishmaniasis in 1 studies
*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira, ME; Gómez-Barrio, A; Heguaburu, V; Marrero-Ponce, Y; Montero-Torres, A; Nakayama, H; Pandolfi, E; Rojas de Arias, A; Roldos, V; Rolón, M; Sanabria, L; Torres, S; Trucco, F; Vega, C; Yaluff, G | 1 |
1 other study(ies) available for lunularin and Leishmaniasis
| Article | Year |
|---|---|
Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies.
Topics: Animals; Antiprotozoal Agents; Bibenzyls; Cattle; Cell Line; Computational Biology; Extracellular Space; Female; Inhibitory Concentration 50; Intracellular Space; Leishmania; Leishmaniasis; Male; Mice; Phenols; Trypanosoma cruzi | 2008 |